<p>Shares of Mankind Pharma made a remarkable debut on the stock exchanges on Tuesday, listing with a premium of over 20 per cent against the issue price of Rs 1,080.</p>.<p>The stock began the trade at Rs 1,300, up 20.37 per cent on the BSE. It further zoomed 24.53 per cent to Rs 1,366.</p>.<p>At the NSE, shares of the company made its debut at Rs 1,300.</p>.<p>The company commanded a market valuation of Rs 54,816.52 crore.</p>.<p>The initial share sale of Mankind Pharma received 15.32 times subscription last month.</p>.<p>The company's IPO was entirely an Offer for Sale (OFS) of 4,00,58,844 equity shares by promoters and other existing shareholders.</p>.<p>Price range for the offer was at Rs 1,026-1,080 a share.</p>.<p>Mankind Pharma is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.</p>
<p>Shares of Mankind Pharma made a remarkable debut on the stock exchanges on Tuesday, listing with a premium of over 20 per cent against the issue price of Rs 1,080.</p>.<p>The stock began the trade at Rs 1,300, up 20.37 per cent on the BSE. It further zoomed 24.53 per cent to Rs 1,366.</p>.<p>At the NSE, shares of the company made its debut at Rs 1,300.</p>.<p>The company commanded a market valuation of Rs 54,816.52 crore.</p>.<p>The initial share sale of Mankind Pharma received 15.32 times subscription last month.</p>.<p>The company's IPO was entirely an Offer for Sale (OFS) of 4,00,58,844 equity shares by promoters and other existing shareholders.</p>.<p>Price range for the offer was at Rs 1,026-1,080 a share.</p>.<p>Mankind Pharma is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.</p>